Education
About Us
Working with TipRanks
Follow Us
Inhibrx Biosciences, Inc. (INBX)
:INBX
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 200.00K | $ 1.80M | $ 2.18M | $ 7.13M | $ 12.81M |
| Gross Profit | $ 200.00K | $ 609.00K | $ -668.00K | $ 4.44M | $ -60.69M |
| Operating Income | $ -331.45M | $ -219.22M | $ -129.12M | $ -76.56M | $ -67.44M |
| EBITDA | $ 1.70B | $ -206.69M | $ -125.82M | $ -76.56M | $ -67.44M |
| Net Income | $ 1.69B | $ -241.36M | $ -145.23M | $ -81.77M | $ -75.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 152.60M | $ 277.92M | $ 273.87M | $ 131.30M | $ 128.66M |
| Total Assets | $ 180.77M | $ 307.89M | $ 290.88M | $ 150.45M | $ 143.74M |
| Total Debt | $ 8.05M | $ 210.14M | $ 202.07M | $ 70.47M | $ 37.45M |
| Net Debt | $ -144.55M | $ -67.78M | $ -71.80M | $ -60.83M | $ -91.21M |
| Total Liabilities | $ 47.18M | $ 264.39M | $ 232.82M | $ 98.07M | $ 68.27M |
| Stockholders' Equity | $ 133.58M | $ 43.50M | $ 58.06M | $ 52.38M | $ 75.47M |
| Cash Flow | |||||
| Free Cash Flow | $ -197.01M | $ -197.90M | $ -115.99M | $ -81.19M | $ -49.33M |
| Operating Cash Flow | $ -194.41M | $ -193.31M | $ -115.30M | $ -80.32M | $ -47.97M |
| Investing Cash Flow | $ -2.60M | $ -4.59M | $ -686.00K | $ -809.00K | $ -1.36M |
| Financing Cash Flow | $ 71.68M | $ 201.96M | $ 258.55M | $ 83.77M | $ 166.46M |